129 related articles for article (PubMed ID: 1917404)
1. Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model (NZB/NZW F1) of Sjögren's syndrome.
Vendramini AC; Soo C; Sullivan DA
Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):3002-6. PubMed ID: 1917404
[TBL] [Abstract][Full Text] [Related]
2. Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome.
Sullivan DA; Edwards JA
J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):237-45. PubMed ID: 9191982
[TBL] [Abstract][Full Text] [Related]
3. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjögren's syndrome.
Sato EH; Sullivan DA
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2632-42. PubMed ID: 8163351
[TBL] [Abstract][Full Text] [Related]
4. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome.
Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA
Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269
[TBL] [Abstract][Full Text] [Related]
5. Impact of androgen therapy in Sjögren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice.
Sato EH; Ariga H; Sullivan DA
Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2537-45. PubMed ID: 1634351
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
[TBL] [Abstract][Full Text] [Related]
7. Androgen control of autoimmune expression in lacrimal glands of MRL/Mp-lpr/lpr mice.
Ariga H; Edwards J; Sullivan DA
Clin Immunol Immunopathol; 1989 Dec; 53(3):499-508. PubMed ID: 2805454
[TBL] [Abstract][Full Text] [Related]
8. Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB/W mouse model of Sjögren's syndrome.
Paranyuk Y; Claros N; Birzgalis A; Moore LC; Brink PR; Walcott B
Curr Eye Res; 2001 Sep; 23(3):199-205. PubMed ID: 11803482
[TBL] [Abstract][Full Text] [Related]
9. The treatment of Sjögren's disease in NZB/NZW F1 hybrid mice with azathioprine: a two-stage study.
Yeoman CM; Franklin CD
Clin Exp Rheumatol; 1994; 12(1):49-53. PubMed ID: 8162642
[TBL] [Abstract][Full Text] [Related]
10. Lacrimal gland, cornea, and tear film in the NZB/NZW F1 hybrid mouse.
Gilbard JP; Hanninen LA; Rothman RC; Kenyon KR
Curr Eye Res; 1987 Oct; 6(10):1237-48. PubMed ID: 3677784
[TBL] [Abstract][Full Text] [Related]
11. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
Jabs DA; Enger C; Prendergast RA
Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
[TBL] [Abstract][Full Text] [Related]
12. Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency?
Sullivan DA; Krenzer KL; Sullivan BD; Tolls DB; Toda I; Dana MR
Invest Ophthalmol Vis Sci; 1999 May; 40(6):1261-5. PubMed ID: 10235562
[TBL] [Abstract][Full Text] [Related]
13. Gender- and androgen-related influence on the expression of proto-oncogene and apoptotic factor mRNAs in lacrimal glands of autoimmune and non-autoimmune mice.
Toda I; Sullivan BD; Wickham LA; Sullivan DA
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):49-61. PubMed ID: 10619357
[TBL] [Abstract][Full Text] [Related]
14. Assessment of sulphasalazine as a treatment modality in Sjögren's disease in NZB/NZW F1 hybrid mice.
Yeoman CM; Franklin CD
Clin Exp Rheumatol; 1996; 14(1):53-7. PubMed ID: 8697658
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical location and hormonal control of androgen receptors in lacrimal tissues of the female MRL/Mp-lpr/lpr mouse model of Sjögren's syndrome.
Ono M; Rocha FJ; Sullivan DA
Exp Eye Res; 1995 Dec; 61(6):659-66. PubMed ID: 8846837
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
17. Effect of low dietary lipid on the development of Sjögren's syndrome and haematological abnormalities in (NZB x NZW)F1 mice.
Swanson CA; Levy JA; Morrow WJ
Ann Rheum Dis; 1989 Sep; 48(9):765-70. PubMed ID: 2802799
[TBL] [Abstract][Full Text] [Related]
18. Sjögren's syndrome in MRL/l and MRL/n mice.
Hoffman RW; Alspaugh MA; Waggie KS; Durham JB; Walker SE
Arthritis Rheum; 1984 Feb; 27(2):157-65. PubMed ID: 6421291
[TBL] [Abstract][Full Text] [Related]
19. The presence of cytotoxic autoantibody to lacrimal gland cells in NZB/W mice.
Ohashi Y; So SK; Minasi PN; Tabbara KF
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):214-9. PubMed ID: 3972503
[TBL] [Abstract][Full Text] [Related]
20. Influence of androgen therapy on lacrimal autoimmune disease in a mouse model of Sjögren's syndrome.
Sullivan DA; Rocha FJ; Sato EH
Adv Exp Med Biol; 1995; 371B():1199-202. PubMed ID: 7502783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
